![](https://www.ltcrc.org/wp-content/uploads/2022/05/vaccine-g18c6497e4_640.jpg)
Sotrovimab No Longer Authorized to Treat COVID-19 in US
For Your Situational Awareness (FYSA): Sotrovimab is no longer authorized to treat COVID-19 in any U.S. region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2 sub-variant